Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 1/2020

Ausgabe 1/2020

Inhaltsverzeichnis ( 24 Artikel )

23.06.2020 | Review | Ausgabe 1/2020

Impact of NR5A2 and RYR2 3′UTR polymorphisms on the risk of breast cancer in a Chinese Han population

Ying Wei, Xiaolin Wang, Zhe Zhang, Changtao Zhao, Yuwei Chang, Zhiqing Bian, Xinhan Zhao

23.06.2020 | Review | Ausgabe 1/2020 Open Access

A systematic review of communication interventions to help healthcare professionals discuss genetic testing for breast cancer

Rachel Starkings, Valerie Shilling, Valerie Jenkins, Lesley Fallowfield

26.06.2020 | Review | Ausgabe 1/2020 Open Access

Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer

Michelle D. Hackshaw, Heather E. Danysh, Jasmeet Singh, Mary E. Ritchey, Amy Ladner, Corina Taitt, D. Ross Camidge, Hiroji Iwata, Charles A. Powell

22.06.2020 | Preclinical study | Ausgabe 1/2020

High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer

Yoshiya Horimoto, Noriko Sasahara, Ritsuko Sasaki, May Thinzar Hlaing, Asumi Sakaguchi, Harumi Saeki, Atsushi Arakawa, Takanori Himuro, Mitsue Saito

23.06.2020 | Preclinical study | Ausgabe 1/2020 Open Access

Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer

Rashmi Verma, Andrew M. Hanby, Kieran Horgan, Eldo T. Verghese, Milene Volpato, Clive R. Carter, Thomas A. Hughes

29.06.2020 | Preclinical study | Ausgabe 1/2020

Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer

Fang-Ming Chen, Li-Ju Huang, Fu Ou-Yang, Jung-Yu Kan, Li-Chun Kao, Ming-Feng Hou

29.06.2020 | Preclinical study | Ausgabe 1/2020

CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA

Xiaowei Yang, Lu Zhao, Jing Pei, Zhaorui Wang, Jingjie Zhang, Benzhong Wang

29.06.2020 | Preclinical study | Ausgabe 1/2020

Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema

Paula M. C. Donahue, Rachelle Crescenzi, Chelsea Lee, Maria Garza, Niral J. Patel, Kalen J. Petersen, Manus J. Donahue

29.06.2020 | Preclinical study | Ausgabe 1/2020

Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers

Dingxie Liu

23.06.2020 | Clinical trial | Ausgabe 1/2020

Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

Ahrong Ham, Min Hwan Kim, Gun Min Kim, Jee Hung Kim, Jee Ye Kim, Hyung Seok Park, Seho Park, Young Up Cho, Byeong Woo Park, Seung Il Kim, Joohyuk Sohn

29.06.2020 | Clinical trial | Ausgabe 1/2020

Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study

Hadeer G. Khalefa, May A. Shawki, Rasha Aboelhassan, Lamia M. El Wakeel

30.06.2020 | Clinical trial | Ausgabe 1/2020

Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy

George E. Naoum, Oluwadamilola T. Oladeru, Andrzej Niemierko, Laura Salama, Jonathan Winograd, Amy Colwell, Waleed O. Arafat, Barbara Smith, Alice Ho, Alphonse G. Taghian

01.07.2020 | Clinical trial | Ausgabe 1/2020 Open Access

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer

Vincent Walter, Chiara Fischer, Thomas M. Deutsch, Catherine Ersing, Juliane Nees, Florian Schütz, Carlo Fremd, Eva-Maria Grischke, Peter Sinn, Sara Y. Brucker, Andreas Schneeweiss, Andreas D. Hartkopf, Markus Wallwiener

01.07.2020 | Clinical trial | Ausgabe 1/2020

Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery

Elyse LeeVan, Be Thi Ho, Sadie Seto, Jeannie Shen

22.06.2020 | Epidemiology | Ausgabe 1/2020 Open Access

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study

Sixten Harborg, Uffe Heide-Jørgensen, Thomas P. Ahern, Marianne Ewertz, Deirdre Cronin-Fenton, Signe Borgquist

22.06.2020 | Epidemiology | Ausgabe 1/2020 Open Access

Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score

Stephanie Robertson, Balazs Acs, Michael Lippert, Johan Hartman

25.06.2020 | Epidemiology | Ausgabe 1/2020

Cardiovascular mortality and morbidity burden in successive and age pre-stratified case–control cohorts of breast cancer women. A population-based study

Lidia Staszewsky, Fabio Robusto, Vito Lepore, Lucia Bisceglia, Vito Petrarolo, Antonio D’Ettorre, Gianni Tognoni, Roberto Latini

26.06.2020 | Epidemiology | Ausgabe 1/2020

Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management

Marianna Cavazza, Helen Banks, Michele Ercolanoni, Gjiliola Cukaj, Giulia Bianchi, Giuseppe Capri, Francesco Longo

26.06.2020 | Epidemiology | Ausgabe 1/2020

Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data

Melissa K. Accordino, Jason D. Wright, Donna Buono, Aijing Lin, Yongmei Huang, Alfred I. Neugut, Grace C. Hillyer, Dawn L. Hershman

27.06.2020 | COVID-19 | Epidemiology | Ausgabe 1/2020 Zur Zeit gratis

Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China

Jing Yao, Yanfang Liu, Jing Cheng

30.06.2020 | Epidemiology | Ausgabe 1/2020

Association between selenium intake and breast cancer risk: results from the Women’s Health Initiative

Dan Guo, Michael Hendryx, Xiaoyun Liang, JoAnn E. Manson, Ka He, Mara Z. Vitolins, Yueyao Li, Juhua Luo

29.06.2020 | Epidemiology | Ausgabe 1/2020

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Diana G. Wang, Dulce M. Barrios, Victoria S. Blinder, Jacqueline F. Bromberg, Pamela R. Drullinsky, Samuel A. Funt, Komal L. Jhaveri, Diana E. Lake, Tomas Lyons, Shanu Modi, Pedram Razavi, Michelle Sidel, Tiffany A. Traina, Linda T. Vahdat, Mario E. Lacouture

28.06.2020 | Letter to the Editor | Ausgabe 1/2020

Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer

Marta Perachino, Francesca Poggio, Matteo Lambertini

29.06.2020 | Letter to the Editor | Ausgabe 1/2020

A case for Tamoxifen with ovarian function suppression

Pallavi Kopparthy, Karen Daily

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise